Chinook Therapeutics Inc. (KDNY) NASDAQ
$40.39 - (-)
Market Cap: -
As of 08/10/23 12:00 AM EDT. Market closed.
Chinook Therapeutics Inc. (KDNY)
NASDAQ
$40.39
- (-)
Market Cap: -
As of 08/10/23 12:00 AM EDT. Market closed.
Add to Portfolio
chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Stephen Isaacs
URL
Address
740 Heinz Ave, California, Berkeley, 94710-2748.
PRICE CHART FOR CHINOOK THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$40.39
Days Range
$40.30 - $40.51
52 week range
- - -
Volume
4,924,994
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
71,804,977
Open
-
Previous Close
$40.39
Days Range
$40.30 - $40.51
52 week range
- - -
Volume
4,924,994
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
71,804,977
FINANCIAL STATEMENTS FOR CHINOOK THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CHINOOK THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| King Andrew James | Chief Scientific Officer | Aug 01, 2023 | Sale | $39.03 | 1,168 | 45,586 | 19,157 | Aug 01, 2023, 07:27 PM |
| Greenman William Mariner | Director | May 30, 2023 | Sale | $23.30 | 1,155 | 26,911 | 23,643 | May 31, 2023, 07:26 PM |
| DOBMEIER ERIC | President, CEO | Apr 24, 2023 | Option Exercise | $0.42 | 25,000 | 10,500 | 326,138 | Apr 26, 2023, 05:19 PM |
| DOBMEIER ERIC | President, CEO | Apr 24, 2023 | Sale | $21.61 | 25,000 | 540,239 | 302,338 | Apr 26, 2023, 05:19 PM |
| Jerel Davis | Director | Apr 17, 2023 | Sale | $20.75 | 295,808 | 6,138,223 | 443,713 | Apr 19, 2023, 05:58 PM |
| King Andrew James | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $0.35 | 2,500 | 875 | 21,992 | Apr 05, 2023, 04:43 PM |
| King Andrew James | Chief Scientific Officer | Apr 03, 2023 | Sale | $23.34 | 5,000 | 116,718 | 16,992 | Apr 05, 2023, 04:43 PM |
| Krishnan Mahesh | Director | Apr 04, 2023 | Sale | $23.01 | 924 | 21,261 | 1,275 | Apr 04, 2023, 09:14 PM |
| Jerel Davis | Director | Mar 01, 2023 | Sale | $22.75 | 400,000 | 9,100,000 | 2,105,107 | Mar 03, 2023, 04:13 PM |
| BJERKHOLT ERIC | Chief Financial Officer | Feb 10, 2023 | Sale | $23.75 | 857 | 20,352 | 38,867 | Feb 15, 2023, 04:41 PM |
| DOBMEIER ERIC | President, CEO | Feb 10, 2023 | Sale | $23.75 | 8,097 | 192,292 | 301,138 | Feb 15, 2023, 04:40 PM |
| Frohlich Tom | Chief Operating Officer | Feb 10, 2023 | Sale | $23.75 | 3,700 | 87,869 | 150,777 | Feb 15, 2023, 04:40 PM |
| King Andrew James | Chief Scientific Officer | Feb 10, 2023 | Sale | $23.75 | 2,392 | 56,806 | 19,492 | Feb 15, 2023, 04:39 PM |
| Frohlich Tom | Chief Operating Officer | Jan 31, 2023 | Sale | $24.68 | 4,566 | 112,700 | 147,674 | Feb 02, 2023, 06:15 PM |
| BJERKHOLT ERIC | Chief Financial Officer | Jan 31, 2023 | Sale | $24.68 | 2,891 | 71,357 | 37,289 | Feb 02, 2023, 06:14 PM |
| King Andrew James | Chief Scientific Officer | Jan 31, 2023 | Sale | $24.68 | 3,244 | 80,069 | 15,081 | Feb 02, 2023, 06:13 PM |
| DOBMEIER ERIC | President, CEO | Jan 30, 2023 | Option Exercise | $0.42 | 25,000 | 10,500 | 296,676 | Feb 01, 2023, 08:32 PM |
| DOBMEIER ERIC | President, CEO | Jan 31, 2023 | Sale | $24.68 | 7,688 | 189,757 | 288,987 | Feb 01, 2023, 08:32 PM |
| DOBMEIER ERIC | President, CEO | Jan 30, 2023 | Sale | $24.54 | 25,000 | 613,613 | 271,676 | Feb 01, 2023, 08:32 PM |
| King Andrew James | Chief Scientific Officer | Jan 03, 2023 | Option Exercise | $0.35 | 7,500 | 2,625 | 19,992 | Jan 04, 2023, 07:44 PM |
| King Andrew James | Chief Scientific Officer | Jan 03, 2023 | Sale | $25.82 | 10,000 | 258,183 | 9,992 | Jan 04, 2023, 07:44 PM |
| Frohlich Tom | Chief Operating Officer | Dec 13, 2022 | Option Exercise | $0.42 | 10,000 | 4,200 | 153,907 | Dec 15, 2022, 04:28 PM |
| Frohlich Tom | Chief Operating Officer | Dec 13, 2022 | Sale | $25.00 | 10,000 | 250,005 | 143,907 | Dec 15, 2022, 04:28 PM |
| DOBMEIER ERIC | President, CEO | Dec 14, 2022 | Option Exercise | $0.35 | 30,000 | 10,500 | 271,676 | Dec 15, 2022, 04:27 PM |
| DOBMEIER ERIC | President, CEO | Dec 01, 2022 | Option Exercise | $0.42 | 60,000 | 25,200 | 271,676 | Dec 02, 2022, 04:26 PM |
| DOBMEIER ERIC | President, CEO | Dec 01, 2022 | Sale | $22.31 | 30,000 | 669,351 | 241,676 | Dec 02, 2022, 04:26 PM |
| BJERKHOLT ERIC | Chief Financial Officer | Dec 01, 2022 | Sale | $22.29 | 5,770 | 128,602 | 32,847 | Dec 02, 2022, 04:25 PM |
| Frohlich Tom | Chief Operating Officer | Nov 07, 2022 | Option Exercise | $0.42 | 10,000 | 4,200 | 153,907 | Nov 09, 2022, 04:21 PM |
| Frohlich Tom | Chief Operating Officer | Nov 07, 2022 | Sale | $22.16 | 10,000 | 221,642 | 143,907 | Nov 09, 2022, 04:21 PM |
| Frohlich Tom | Chief Operating Officer | Oct 06, 2022 | Sale | $19.69 | 7,360 | 144,933 | 143,907 | Oct 11, 2022, 04:33 PM |
| King Andrew James | Chief Scientific Officer | Oct 06, 2022 | Sale | $19.69 | 3,557 | 70,044 | 12,492 | Oct 11, 2022, 04:32 PM |
| Thomas Dolca | Director | Sep 02, 2022 | Buy | $21.22 | 10,000 | 212,194 | 10,000 | Sep 06, 2022, 04:35 PM |
| King Andrew James | Chief Scientific Officer | Aug 04, 2022 | Option Exercise | $0.35 | 5,000 | 1,750 | 10,897 | Aug 05, 2022, 05:09 PM |
| King Andrew James | Chief Scientific Officer | Aug 04, 2022 | Sale | $20.00 | 5,000 | 100,000 | 5,897 | Aug 05, 2022, 05:09 PM |
| King Andrew James | Chief Scientific Officer | Jul 11, 2022 | Option Exercise | $0.35 | 5,000 | 1,750 | 10,897 | Jul 13, 2022, 04:11 PM |
| King Andrew James | Chief Scientific Officer | Jul 11, 2022 | Sale | $18.09 | 5,000 | 90,468 | 5,897 | Jul 13, 2022, 04:11 PM |
| AKKARAJU SRINIVAS | Director | May 27, 2022 | Buy | $14.00 | 570,000 | 7,980,000 | 5,161,888 | Jun 01, 2022, 04:13 PM |
| DOBMEIER ERIC | President, CEO | May 25, 2022 | Buy | $13.03 | 5,000 | 65,148 | 205,880 | May 27, 2022, 06:17 PM |
| King Andrew James | Chief Scientific Officer | Apr 11, 2022 | Option Exercise | $0.35 | 5,000 | 1,750 | 10,897 | Apr 13, 2022, 05:34 PM |
| King Andrew James | Chief Scientific Officer | Apr 11, 2022 | Sale | $15.36 | 5,000 | 76,812 | 5,897 | Apr 13, 2022, 05:34 PM |
| King Andrew James | Chief Scientific Officer | Feb 18, 2022 | Sale | $13.00 | 2,500 | 32,500 | 5,897 | Feb 23, 2022, 05:17 PM |
| BJERKHOLT ERIC | Chief Financial Officer | Feb 11, 2022 | Sale | $12.74 | 895 | 11,403 | 22,203 | Feb 14, 2022, 07:58 PM |
| King Andrew James | Chief Scientific Officer | Feb 11, 2022 | Sale | $12.74 | 2,498 | 31,827 | 8,397 | Feb 14, 2022, 07:56 PM |
| Glicklich Alan | Chief Medical Officer | Feb 11, 2022 | Sale | $12.74 | 2,391 | 30,464 | 7,891 | Feb 14, 2022, 07:56 PM |
| Frohlich Tom | Chief Operating Officer | Feb 11, 2022 | Sale | $12.74 | 3,735 | 47,587 | 137,685 | Feb 14, 2022, 07:53 PM |
| King Andrew James | Chief Scientific Officer | Feb 10, 2022 | Option Exercise | $0.35 | 2,500 | 875 | 6,594 | Feb 11, 2022, 05:26 PM |
| King Andrew James | Chief Scientific Officer | Feb 10, 2022 | Sale | $13.31 | 2,500 | 33,275 | 4,094 | Feb 11, 2022, 05:26 PM |
| Versant Venture Capital VII, L.P. | 10% Owner | Jan 03, 2022 | Sale | $16.00 | 400,000 | 6,400,080 | 1,863,197 | Jan 05, 2022, 05:16 PM |
| Versant Venture Capital VII, L.P. | 10% Owner | Jan 03, 2022 | Sale | $16.00 | 600,000 | 9,600,120 | 3,623,023 | Jan 05, 2022, 05:16 PM |
| Jerel Davis | Director | Jan 03, 2022 | Sale | $16.00 | 1,000,000 | 16,000,200 | 3,623,023 | Jan 05, 2022, 05:13 PM |
| DOBMEIER ERIC | President, CEO | Dec 23, 2021 | Option Exercise | $0.35 | 40,000 | 14,000 | 180,633 | Dec 27, 2021, 06:24 PM |
| BJERKHOLT ERIC | Chief Financial Officer | Dec 01, 2021 | Option Exercise | $16.02 | 5,750 | 92,097 | 20,664 | Dec 03, 2021, 07:05 PM |
| AKKARAJU SRINIVAS | Director | Nov 15, 2021 | Buy | $14.00 | 1,215,000 | 17,010,000 | 4,591,888 | Nov 17, 2021, 12:05 PM |
| Frohlich Tom | Chief Operating Officer | Nov 10, 2021 | Sale | $15.48 | 6,230 | 96,440 | 134,619 | Nov 12, 2021, 08:00 PM |
| King Andrew James | Chief Scientific Officer | Nov 09, 2021 | Option Exercise | $0.35 | 2,500 | 875 | 9,094 | Nov 12, 2021, 07:59 PM |
| King Andrew James | Chief Scientific Officer | Nov 09, 2021 | Sale | $13.53 | 5,000 | 67,660 | 4,094 | Nov 12, 2021, 07:59 PM |
| Frohlich Tom | Chief Operating Officer | Nov 05, 2021 | Option Exercise | $0.42 | 15,000 | 6,300 | 174,619 | Nov 09, 2021, 09:40 PM |
| Frohlich Tom | Chief Operating Officer | Nov 08, 2021 | Sale | $15.17 | 13,770 | 208,938 | 140,849 | Nov 09, 2021, 09:40 PM |
| Frohlich Tom | Chief Operating Officer | Nov 05, 2021 | Sale | $14.00 | 20,000 | 280,000 | 159,619 | Nov 09, 2021, 09:40 PM |
| Greenman William Mariner | Director | Oct 21, 2021 | Option Exercise | $2.60 | 1,663 | 4,324 | 21,498 | Oct 22, 2021, 06:47 PM |
| Frohlich Tom | Chief Operating Officer | Oct 06, 2021 | Option Exercise | $12.37 | 7,359 | 91,021 | 159,619 | Oct 08, 2021, 06:51 PM |
| King Andrew James | Chief Scientific Officer | Oct 06, 2021 | Option Exercise | $12.37 | 3,557 | 43,995 | 6,594 | Oct 08, 2021, 06:48 PM |
| Glicklich Alan | Chief Medical Officer | Oct 06, 2021 | Option Exercise | $12.37 | 2,489 | 30,785 | 4,614 | Oct 08, 2021, 06:46 PM |
| Frohlich Tom | Chief Operating Officer | Sep 24, 2021 | Option Exercise | $0.42 | 20,000 | 8,400 | 153,398 | Sep 28, 2021, 04:46 PM |
| Frohlich Tom | Chief Operating Officer | Sep 24, 2021 | Sale | $13.00 | 20,000 | 260,000 | 133,398 | Sep 24, 2021, 08:16 PM |
| DOBMEIER ERIC | President, CEO | Sep 20, 2021 | Buy | $12.00 | 2,000 | 24,000 | 109,837 | Sep 22, 2021, 07:23 PM |
| Jerel Davis | Director | Aug 27, 2021 | Sale | $14.00 | 850,000 | 11,900,000 | 4,223,023 | Aug 31, 2021, 07:06 PM |
| Versant Venture Capital VII, L.P. | 10% Owner | Aug 27, 2021 | Sale | $14.00 | 340,000 | 4,760,000 | 2,171,197 | Aug 31, 2021, 07:06 PM |
| Versant Venture Capital VII, L.P. | 10% Owner | Aug 27, 2021 | Sale | $14.00 | 510,000 | 7,140,000 | 4,223,023 | Aug 31, 2021, 07:06 PM |
| AKKARAJU SRINIVAS | Director | Aug 18, 2021 | Buy | $11.98 | 208,500 | 2,497,830 | 3,376,888 | Aug 20, 2021, 05:37 PM |
| DOBMEIER ERIC | President, CEO | Aug 18, 2021 | Buy | $11.74 | 7,000 | 82,163 | 104,837 | Aug 19, 2021, 05:55 PM |
| DOBMEIER ERIC | President, CEO | Aug 19, 2021 | Buy | $12.00 | 3,000 | 36,000 | 107,837 | Aug 19, 2021, 05:55 PM |
| Glicklich Alan | Chief Medical Officer | Jun 16, 2021 | Option Exercise | $0.42 | 20,000 | 8,400 | 20,000 | Jun 17, 2021, 06:40 PM |
| Glicklich Alan | Chief Medical Officer | Jun 16, 2021 | Sale | $16.35 | 20,000 | 326,968 | 0 | Jun 17, 2021, 06:40 PM |
| DOBMEIER ERIC | President, CEO | Jun 14, 2021 | Option Exercise | $0.35 | 20,000 | 7,000 | 97,837 | Jun 15, 2021, 05:24 PM |
| DOBMEIER ERIC | President, CEO | Dec 21, 2020 | Option Exercise | $0.35 | 20,000 | 7,000 | 76,837 | Dec 22, 2020, 07:47 PM |
| DOBMEIER ERIC | President, CEO | Dec 08, 2020 | Buy | $13.24 | 2,000 | 26,483 | 54,837 | Dec 10, 2020, 05:38 PM |
| DOBMEIER ERIC | President, CEO | Dec 09, 2020 | Buy | $13.07 | 2,000 | 26,150 | 56,837 | Dec 10, 2020, 05:38 PM |
| DOBMEIER ERIC | President, CEO | Nov 23, 2020 | Buy | $13.67 | 929 | 12,699 | 52,837 | Nov 23, 2020, 07:26 PM |
| DOBMEIER ERIC | President, CEO | Nov 20, 2020 | Buy | $13.69 | 571 | 7,817 | 51,908 | Nov 23, 2020, 07:26 PM |
| DOBMEIER ERIC | President, CEO | Nov 19, 2020 | Buy | $13.50 | 500 | 6,750 | 51,337 | Nov 23, 2020, 07:26 PM |
| DOBMEIER ERIC | President, CEO | Nov 11, 2020 | Buy | $13.75 | 2,500 | 34,375 | 50,837 | Nov 13, 2020, 06:13 PM |
| DOBMEIER ERIC | President, CEO | Nov 10, 2020 | Buy | $13.86 | 2,000 | 27,720 | 48,337 | Nov 13, 2020, 06:13 PM |
| ISAACS STEPHEN T | President and CEO | Sep 15, 2020 | Sale | $2.39 | 32,481 | 77,691 | 279,166 | Sep 17, 2020, 08:17 PM |
| Templeman Blaine | Chief Legal Officer | Sep 15, 2020 | Sale | $2.39 | 12,369 | 29,585 | 121,916 | Sep 17, 2020, 08:16 PM |
| Ferber Celeste | SVP, GC and Secretary | Sep 15, 2020 | Sale | $2.39 | 2,396 | 5,731 | 38,687 | Sep 17, 2020, 08:15 PM |
| Nuyten Dimitry SA | Chief Medical Officer | Aug 07, 2020 | Sale | $2.55 | 3,538 | 9,036 | 8,462 | Aug 11, 2020, 04:06 PM |
| Templeman Blaine | Chief Legal Officer | Aug 07, 2020 | Sale | $2.55 | 7,951 | 20,308 | 134,285 | Aug 11, 2020, 04:05 PM |
| Ferber Celeste | SVP, GC and Secretary | Aug 07, 2020 | Sale | $2.55 | 7,951 | 20,308 | 41,083 | Aug 11, 2020, 04:04 PM |
| Greenman William Mariner | Director | Mar 18, 2020 | Option Exercise | $0.45 | 19,835 | 8,926 | 19,835 | Mar 20, 2020, 05:18 PM |
| ISAACS STEPHEN T | President and CEO | Mar 18, 2020 | Option Exercise | $0.45 | 21,618 | 9,728 | 311,647 | Mar 20, 2020, 05:17 PM |
| van Elsas Andrea | Chief Scientific Officer | Feb 25, 2020 | Sale | $3.51 | 6,823 | 23,954 | 438,367 | Feb 26, 2020, 06:58 PM |
| van Elsas Andrea | Chief Scientific Officer | Jan 03, 2020 | Sale | $1.19 | 73,311 | 87,108 | 445,190 | Jan 06, 2020, 06:38 PM |
| Templeman Blaine | Chief Legal Officer | Dec 12, 2019 | Sale | $1.16 | 1,264 | 1,470 | 117,736 | Dec 16, 2019, 04:14 PM |
| Ferber Celeste | SVP, GC and Secretary | Dec 12, 2019 | Sale | $1.16 | 408 | 475 | 26,534 | Dec 16, 2019, 04:13 PM |
| van Elsas Andrea | Chief Scientific Officer | Dec 12, 2019 | Sale | $1.16 | 2,192 | 2,550 | 518,501 | Dec 16, 2019, 04:13 PM |
| ISAACS STEPHEN T | President and CEO | Dec 12, 2019 | Sale | $1.16 | 5,897 | 6,860 | 290,029 | Dec 16, 2019, 04:12 PM |
| Haghighat Ross | Director | Sep 16, 2019 | Option Exercise | $0.64 | 55,539 | 35,527 | 87,122 | Sep 18, 2019, 07:00 PM |
| Ferber Celeste | SVP, GC and Secretary | Sep 13, 2019 | Sale | $1.31 | 2,494 | 3,257 | 28,044 | Sep 17, 2019, 06:34 PM |
| ISAACS STEPHEN T | President and CEO | Sep 13, 2019 | Sale | $1.31 | 31,098 | 40,608 | 295,926 | Sep 17, 2019, 06:34 PM |
| van Elsas Andrea | Chief Scientific Officer | Sep 13, 2019 | Sale | $1.31 | 18,593 | 24,279 | 521,327 | Sep 17, 2019, 06:33 PM |
| Templeman Blaine | Chief Legal Officer | Sep 13, 2019 | Sale | $1.31 | 12,878 | 16,817 | 122,888 | Sep 17, 2019, 06:32 PM |
| Ferber Celeste | SVP, GC and Secretary | May 20, 2019 | Sale | $3.21 | 2,000 | 6,413 | 29,436 | May 22, 2019, 07:04 PM |
| Lew Jennifer | Chief Financial Officer | May 01, 2019 | Option Exercise | $1.25 | 18,602 | 23,306 | 147,299 | May 03, 2019, 07:17 PM |
| Lew Jennifer | Chief Financial Officer | May 01, 2019 | Sale | $4.20 | 18,602 | 78,136 | 135,155 | May 03, 2019, 07:17 PM |
| Lew Jennifer | Chief Financial Officer | Apr 08, 2019 | Option Exercise | $1.25 | 18,601 | 23,305 | 147,299 | Apr 10, 2019, 07:09 PM |
| Lew Jennifer | Chief Financial Officer | Apr 08, 2019 | Sale | $4.07 | 18,601 | 75,775 | 135,155 | Apr 10, 2019, 07:09 PM |
| van Elsas Andrea | Chief Scientific Officer | Mar 19, 2019 | Sale | $3.96 | 6,081 | 24,107 | 239,557 | Mar 21, 2019, 05:35 PM |
| van Elsas Andrea | Chief Scientific Officer | Feb 26, 2019 | Sale | $4.25 | 6,844 | 29,120 | 245,638 | Feb 27, 2019, 07:07 PM |
| van Elsas Andrea | Chief Scientific Officer | Dec 28, 2018 | Sale | $2.57 | 1,907 | 4,901 | 252,482 | Dec 31, 2018, 04:02 PM |
| Lew Jennifer | Chief Financial Officer | Dec 12, 2018 | Sale | $2.93 | 1,035 | 3,035 | 135,155 | Dec 14, 2018, 04:19 PM |
| Templeman Blaine | Chief Legal Officer | Dec 12, 2018 | Sale | $2.93 | 1,241 | 3,639 | 129,878 | Dec 14, 2018, 04:18 PM |
| ISAACS STEPHEN T | President and CEO | Dec 12, 2018 | Sale | $2.93 | 5,829 | 17,091 | 327,024 | Dec 14, 2018, 04:17 PM |
| van Elsas Andrea | Chief Scientific Officer | Dec 12, 2018 | Sale | $2.93 | 2,171 | 6,365 | 254,389 | Dec 14, 2018, 04:15 PM |
| Templeman Blaine | Chief Legal Officer | Nov 20, 2018 | Sale | $2.91 | 843 | 2,453 | 131,119 | Nov 20, 2018, 07:58 PM |
| van Elsas Andrea | Chief Scientific Officer | Sep 24, 2018 | Sale | $5.83 | 7,726 | 45,022 | 256,560 | Sep 25, 2018, 08:11 PM |
| Templeman Blaine | Chief Legal Officer | Sep 24, 2018 | Sale | $5.81 | 10,262 | 59,613 | 131,119 | Sep 25, 2018, 08:10 PM |
| Templeman Blaine | Executive VP, General Counsel | Sep 13, 2018 | Sale | $6.50 | 6,056 | 39,360 | 141,381 | Sep 14, 2018, 07:29 PM |
| van Elsas Andrea | Chief Scientific Officer | Sep 13, 2018 | Sale | $6.50 | 9,754 | 63,394 | 264,286 | Sep 14, 2018, 07:28 PM |
| Lew Jennifer | Chief Financial Officer | Sep 13, 2018 | Sale | $6.50 | 5,623 | 36,546 | 136,190 | Sep 14, 2018, 07:27 PM |
| Sacks Natalie | Chief Medical Officer | Sep 13, 2018 | Sale | $6.50 | 3,028 | 19,680 | 173,720 | Sep 14, 2018, 07:25 PM |
| ISAACS STEPHEN T | President and CEO | Sep 13, 2018 | Sale | $6.50 | 24,143 | 156,913 | 332,853 | Sep 14, 2018, 07:24 PM |
| ISAACS STEPHEN T | President and CEO | Sep 06, 2018 | Option Exercise | $1.00 | 46,987 | 46,987 | 252,733 | Sep 06, 2018, 07:42 PM |
| ISAACS STEPHEN T | President and CEO | Sep 05, 2018 | Option Exercise | $1.00 | 15,585 | 15,585 | 221,331 | Sep 06, 2018, 07:42 PM |
| ISAACS STEPHEN T | President and CEO | Sep 05, 2018 | Sale | $7.90 | 15,585 | 123,134 | 205,746 | Sep 06, 2018, 07:42 PM |
| ISAACS STEPHEN T | President and CEO | Sep 06, 2018 | Sale | $7.92 | 46,987 | 372,024 | 205,746 | Sep 06, 2018, 07:42 PM |
| Sacks Natalie | Chief Medical Officer | Sep 04, 2018 | Sale | $7.13 | 4,504 | 32,099 | 89,548 | Sep 06, 2018, 07:40 PM |
| van Elsas Andrea | Chief Scientific Officer | Jul 17, 2018 | Sale | $6.96 | 10,454 | 72,803 | 206,215 | Jul 19, 2018, 07:39 PM |
| ISAACS STEPHEN T | President and CEO | Jun 01, 2018 | Option Exercise | $1.00 | 40,000 | 40,000 | 245,746 | Jun 05, 2018, 08:58 PM |
| ISAACS STEPHEN T | President and CEO | Jun 01, 2018 | Sale | $8.68 | 40,000 | 347,004 | 205,746 | Jun 05, 2018, 08:58 PM |
| Templeman Blaine | Chief Legal Officer | May 17, 2018 | Sale | $8.15 | 2,000 | 16,300 | 69,937 | May 21, 2018, 06:25 PM |
| ISAACS STEPHEN T | President and CEO | May 09, 2018 | Option Exercise | $0.97 | 40,000 | 38,976 | 245,746 | May 11, 2018, 05:00 PM |
| ISAACS STEPHEN T | President and CEO | May 09, 2018 | Sale | $8.01 | 40,000 | 320,348 | 205,746 | May 11, 2018, 05:00 PM |
| ISAACS STEPHEN T | President and CEO | Apr 02, 2018 | Option Exercise | $0.82 | 40,000 | 32,800 | 245,746 | Apr 04, 2018, 06:26 PM |
| ISAACS STEPHEN T | President and CEO | Apr 02, 2018 | Sale | $8.91 | 40,000 | 356,400 | 205,746 | Apr 04, 2018, 06:26 PM |
| ISAACS STEPHEN T | President and CEO | Mar 09, 2018 | Option Exercise | $0.50 | 46,417 | 23,165 | 252,163 | Mar 09, 2018, 07:40 PM |
| ISAACS STEPHEN T | President and CEO | Mar 08, 2018 | Option Exercise | $0.45 | 25,634 | 11,535 | 231,380 | Mar 09, 2018, 07:40 PM |
| ISAACS STEPHEN T | President and CEO | Mar 09, 2018 | Sale | $8.77 | 46,417 | 407,268 | 226,351 | Mar 09, 2018, 07:40 PM |
| ISAACS STEPHEN T | President and CEO | Mar 08, 2018 | Sale | $7.95 | 25,634 | 203,790 | 205,746 | Mar 09, 2018, 07:40 PM |
| van Elsas Andrea | Chief Scientific Officer | Feb 26, 2018 | Sale | $6.48 | 6,874 | 44,522 | 216,669 | Feb 27, 2018, 06:56 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jan 25, 2018 | Option Exercise | $0.82 | 60,000 | 49,200 | 250,745 | Jan 26, 2018, 07:15 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jan 25, 2018 | Option Exercise | $0.01 | 3,317 | 33 | 254,062 | Jan 26, 2018, 07:15 PM |
| ISAACS STEPHEN T | President and CEO | Jan 05, 2018 | Option Exercise | $0.45 | 7,949 | 3,577 | 213,695 | Jan 09, 2018, 05:48 PM |
| ISAACS STEPHEN T | President and CEO | Jan 05, 2018 | Sale | $7.95 | 7,949 | 63,195 | 205,746 | Jan 09, 2018, 05:48 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Dec 29, 2017 | Option Exercise | $1.45 | 52,000 | 75,400 | 124,603 | Jan 03, 2018, 07:03 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jan 02, 2018 | Option Exercise | $1.04 | 20,000 | 20,767 | 210,745 | Jan 03, 2018, 06:59 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Dec 29, 2017 | Option Exercise | $0.82 | 42,000 | 34,440 | 190,745 | Jan 03, 2018, 06:59 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jan 02, 2018 | Sale | $7.61 | 20,000 | 152,142 | 190,745 | Jan 03, 2018, 06:59 PM |
| Templeman Blaine | Executive VP, General Counsel | Dec 18, 2017 | Sale | $8.25 | 2,884 | 23,793 | 69,937 | Dec 20, 2017, 06:52 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Dec 15, 2017 | Option Exercise | $1.45 | 64,108 | 92,957 | 137,826 | Dec 15, 2017, 08:02 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Dec 15, 2017 | Sale | $8.11 | 65,223 | 529,187 | 72,603 | Dec 15, 2017, 08:02 PM |
| van Elsas Andrea | Chief Scientific Officer | Sep 13, 2017 | Sale | $10.99 | 4,922 | 54,072 | 202,581 | Dec 15, 2017, 07:58 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Dec 01, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 83,718 | Dec 04, 2017, 07:59 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Dec 01, 2017 | Sale | $9.40 | 10,000 | 93,998 | 73,718 | Dec 04, 2017, 07:59 PM |
| Lew Jennifer | Sr. Vice President of Finance | Dec 01, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 68,938 | Dec 04, 2017, 07:57 PM |
| Lew Jennifer | Sr. Vice President of Finance | Dec 01, 2017 | Sale | $9.46 | 6,600 | 62,433 | 62,338 | Dec 04, 2017, 07:57 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Dec 01, 2017 | Option Exercise | $1.04 | 20,000 | 20,767 | 168,745 | Dec 04, 2017, 07:56 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Dec 01, 2017 | Sale | $9.34 | 20,000 | 186,882 | 148,745 | Dec 04, 2017, 07:56 PM |
| ISAACS STEPHEN T | President and CEO | Dec 01, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 213,921 | Dec 04, 2017, 07:53 PM |
| ISAACS STEPHEN T | President and CEO | Dec 01, 2017 | Sale | $9.38 | 40,000 | 375,028 | 173,921 | Dec 04, 2017, 07:53 PM |
| Templeman Blaine | Executive VP, General Counsel | Nov 17, 2017 | Sale | $8.85 | 243 | 2,151 | 58,834 | Nov 17, 2017, 06:43 PM |
| Lew Jennifer | Sr. Vice President of Finance | Nov 15, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 68,938 | Nov 17, 2017, 06:42 PM |
| Lew Jennifer | Sr. Vice President of Finance | Nov 15, 2017 | Sale | $8.95 | 6,600 | 59,070 | 62,338 | Nov 17, 2017, 06:42 PM |
| ISAACS STEPHEN T | President and CEO | Nov 13, 2017 | Option Exercise | $0.45 | 3,400 | 1,530 | 177,321 | Nov 14, 2017, 06:20 PM |
| ISAACS STEPHEN T | President and CEO | Nov 10, 2017 | Option Exercise | $0.45 | 16,400 | 7,380 | 190,321 | Nov 14, 2017, 06:20 PM |
| ISAACS STEPHEN T | President and CEO | Nov 13, 2017 | Sale | $8.00 | 3,400 | 27,215 | 173,921 | Nov 14, 2017, 06:20 PM |
| ISAACS STEPHEN T | President and CEO | Nov 10, 2017 | Sale | $7.96 | 16,400 | 130,508 | 173,921 | Nov 14, 2017, 06:20 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Nov 13, 2017 | Option Exercise | $0.52 | 4,062 | 2,112 | 77,780 | Nov 14, 2017, 06:09 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Nov 10, 2017 | Option Exercise | $0.52 | 1,815 | 944 | 75,533 | Nov 14, 2017, 06:09 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Nov 10, 2017 | Sale | $8.01 | 1,815 | 14,544 | 73,718 | Nov 14, 2017, 06:09 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Nov 13, 2017 | Sale | $8.00 | 4,062 | 32,496 | 73,718 | Nov 14, 2017, 06:09 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 06, 2017 | Option Exercise | $1.04 | 20,000 | 20,767 | 168,745 | Nov 08, 2017, 08:01 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 06, 2017 | Sale | $7.97 | 20,000 | 159,312 | 148,745 | Nov 08, 2017, 08:01 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Nov 06, 2017 | Option Exercise | $0.52 | 4,123 | 2,144 | 77,841 | Nov 08, 2017, 07:59 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Nov 06, 2017 | Sale | $8.04 | 4,123 | 33,132 | 73,718 | Nov 08, 2017, 07:59 PM |
| ISAACS STEPHEN T | President and CEO | Nov 07, 2017 | Option Exercise | $0.45 | 3,800 | 1,710 | 177,721 | Nov 08, 2017, 07:56 PM |
| ISAACS STEPHEN T | President and CEO | Nov 06, 2017 | Option Exercise | $0.45 | 16,400 | 7,380 | 190,321 | Nov 08, 2017, 07:56 PM |
| ISAACS STEPHEN T | President and CEO | Nov 07, 2017 | Sale | $7.95 | 3,800 | 30,223 | 173,921 | Nov 08, 2017, 07:56 PM |
| ISAACS STEPHEN T | President and CEO | Nov 06, 2017 | Sale | $7.98 | 16,400 | 130,934 | 173,921 | Nov 08, 2017, 07:56 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Oct 02, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 83,718 | Oct 04, 2017, 08:31 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Oct 02, 2017 | Sale | $10.59 | 10,000 | 105,870 | 73,718 | Oct 04, 2017, 08:31 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Oct 02, 2017 | Option Exercise | $1.36 | 20,000 | 27,148 | 168,745 | Oct 04, 2017, 08:26 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Oct 02, 2017 | Sale | $10.75 | 20,000 | 215,060 | 148,745 | Oct 04, 2017, 08:26 PM |
| ISAACS STEPHEN T | President and CEO | Oct 02, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 213,921 | Oct 04, 2017, 08:23 PM |
| ISAACS STEPHEN T | President and CEO | Oct 02, 2017 | Sale | $10.78 | 40,000 | 431,032 | 173,921 | Oct 04, 2017, 08:23 PM |
| Lew Jennifer | Sr. Vice President of Finance | Oct 02, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 68,938 | Oct 04, 2017, 08:21 PM |
| Lew Jennifer | Sr. Vice President of Finance | Oct 02, 2017 | Sale | $10.61 | 6,600 | 69,995 | 62,338 | Oct 04, 2017, 08:21 PM |
| Templeman Blaine | Executive VP, General Counsel | Sep 18, 2017 | Sale | $11.20 | 2,884 | 32,301 | 58,834 | Sep 20, 2017, 07:11 PM |
| ISAACS STEPHEN T | President and CEO | Sep 13, 2017 | Sale | $10.99 | 12,204 | 134,071 | 173,921 | Sep 14, 2017, 09:25 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Sep 13, 2017 | Sale | $10.99 | 4,859 | 53,380 | 148,745 | Sep 14, 2017, 09:24 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Sep 13, 2017 | Sale | $10.99 | 3,557 | 39,076 | 73,718 | Sep 14, 2017, 09:22 PM |
| Lew Jennifer | Sr. Vice President of Finance | Sep 13, 2017 | Sale | $10.99 | 3,557 | 39,076 | 62,338 | Sep 14, 2017, 09:21 PM |
| van Elsas Andrea | Chief Scientific Officer | Sep 13, 2017 | Sale | $10.99 | 4,922 | 54,072 | 207,231 | Sep 14, 2017, 09:20 PM |
| Templeman Blaine | Executive VP, General Counsel | Sep 13, 2017 | Sale | $10.99 | 3,557 | 39,076 | 61,718 | Sep 14, 2017, 09:19 PM |
| Sacks Natalie | Chief Medical Officer | Sep 01, 2017 | Sale | $11.71 | 4,885 | 57,196 | 45,115 | Sep 06, 2017, 04:32 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Sep 01, 2017 | Option Exercise | $1.24 | 20,000 | 24,800 | 140,979 | Sep 06, 2017, 04:30 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Sep 01, 2017 | Sale | $11.70 | 20,000 | 233,980 | 120,979 | Sep 06, 2017, 04:30 PM |
| Lew Jennifer | Sr. Vice President of Finance | Sep 01, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 49,195 | Sep 06, 2017, 04:29 PM |
| Lew Jennifer | Sr. Vice President of Finance | Sep 01, 2017 | Sale | $11.70 | 6,600 | 77,242 | 42,595 | Sep 06, 2017, 04:29 PM |
| ISAACS STEPHEN T | President and CEO | Sep 01, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 144,025 | Sep 06, 2017, 04:28 PM |
| ISAACS STEPHEN T | President and CEO | Sep 01, 2017 | Sale | $11.71 | 40,000 | 468,596 | 104,025 | Sep 06, 2017, 04:28 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Sep 01, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 59,300 | Sep 06, 2017, 04:27 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Sep 01, 2017 | Sale | $11.69 | 10,000 | 116,948 | 49,300 | Sep 06, 2017, 04:27 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2017 | Option Exercise | $1.00 | 9,088 | 9,088 | 48,988 | Aug 11, 2017, 08:03 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Aug 10, 2017 | Option Exercise | $1.00 | 40,912 | 40,912 | 80,812 | Aug 11, 2017, 08:03 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2017 | Sale | $11.17 | 9,088 | 101,538 | 39,900 | Aug 11, 2017, 08:03 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Aug 10, 2017 | Sale | $11.43 | 40,912 | 467,665 | 39,900 | Aug 11, 2017, 08:03 PM |
| ISAACS STEPHEN T | President and CEO | Aug 07, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 144,025 | Aug 09, 2017, 07:46 PM |
| ISAACS STEPHEN T | President and CEO | Aug 07, 2017 | Sale | $12.19 | 40,000 | 487,564 | 104,025 | Aug 09, 2017, 07:46 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Aug 08, 2017 | Option Exercise | $1.27 | 14,189 | 18,004 | 135,168 | Aug 09, 2017, 07:45 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Aug 07, 2017 | Option Exercise | $1.22 | 25,811 | 31,616 | 146,790 | Aug 09, 2017, 07:45 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Aug 08, 2017 | Sale | $12.16 | 14,189 | 172,550 | 120,979 | Aug 09, 2017, 07:45 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Aug 07, 2017 | Sale | $12.17 | 25,811 | 314,233 | 120,979 | Aug 09, 2017, 07:45 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Aug 07, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 59,300 | Aug 09, 2017, 07:44 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Aug 07, 2017 | Sale | $12.18 | 10,000 | 121,795 | 49,300 | Aug 09, 2017, 07:44 PM |
| Lew Jennifer | Sr. Vice President of Finance | Aug 07, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 49,195 | Aug 09, 2017, 07:41 PM |
| Lew Jennifer | Sr. Vice President of Finance | Aug 07, 2017 | Sale | $12.17 | 6,600 | 80,290 | 42,595 | Aug 09, 2017, 07:41 PM |
| Lew Jennifer | Sr. Vice President of Finance | Jul 03, 2017 | Option Exercise | $0.82 | 12,000 | 9,840 | 54,595 | Jul 06, 2017, 07:13 PM |
| Lew Jennifer | Sr. Vice President of Finance | Jul 03, 2017 | Sale | $11.14 | 12,000 | 133,632 | 42,595 | Jul 06, 2017, 07:13 PM |
| ISAACS STEPHEN T | President and CEO | Jul 03, 2017 | Option Exercise | $0.50 | 40,000 | 19,965 | 144,025 | Jul 06, 2017, 07:12 PM |
| ISAACS STEPHEN T | President and CEO | Jul 03, 2017 | Sale | $11.06 | 38,659 | 427,634 | 105,366 | Jul 06, 2017, 07:12 PM |
| ISAACS STEPHEN T | President and CEO | Jul 05, 2017 | Sale | $11.01 | 1,341 | 14,763 | 104,025 | Jul 06, 2017, 07:12 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Jul 03, 2017 | Option Exercise | $0.48 | 10,000 | 4,826 | 59,300 | Jul 06, 2017, 07:11 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Jul 03, 2017 | Sale | $11.02 | 10,000 | 110,167 | 49,300 | Jul 06, 2017, 07:11 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2017 | Option Exercise | $0.52 | 33,688 | 17,518 | 73,588 | Jul 06, 2017, 07:10 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 03, 2017 | Option Exercise | $0.52 | 11,800 | 6,136 | 51,700 | Jul 06, 2017, 07:10 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 06, 2017 | Option Exercise | $0.52 | 4,512 | 2,346 | 44,412 | Jul 06, 2017, 07:10 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2017 | Sale | $11.46 | 33,688 | 385,936 | 39,900 | Jul 06, 2017, 07:10 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 03, 2017 | Sale | $11.02 | 11,800 | 130,028 | 39,900 | Jul 06, 2017, 07:10 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 06, 2017 | Sale | $11.23 | 4,512 | 50,673 | 39,900 | Jul 06, 2017, 07:10 PM |
| Lew Jennifer | Sr. Vice President of Finance | Jun 28, 2017 | Option Exercise | $0.82 | 12,000 | 9,840 | 54,595 | Jun 30, 2017, 06:03 PM |
| Lew Jennifer | Sr. Vice President of Finance | Jun 28, 2017 | Sale | $11.19 | 12,000 | 134,236 | 42,595 | Jun 30, 2017, 06:03 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jun 28, 2017 | Option Exercise | $1.45 | 40,000 | 58,000 | 160,979 | Jun 30, 2017, 06:01 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jun 28, 2017 | Sale | $11.26 | 40,000 | 450,568 | 120,979 | Jun 30, 2017, 06:01 PM |
| ISAACS STEPHEN T | President and CEO | Jun 19, 2017 | Option Exercise | $0.52 | 40,000 | 20,800 | 144,025 | Jun 21, 2017, 06:56 PM |
| ISAACS STEPHEN T | President and CEO | Jun 19, 2017 | Sale | $10.50 | 40,000 | 420,164 | 104,025 | Jun 21, 2017, 06:56 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jun 05, 2017 | Option Exercise | $0.52 | 17,577 | 9,140 | 57,477 | Jun 05, 2017, 07:25 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jun 02, 2017 | Option Exercise | $0.52 | 48,753 | 25,352 | 88,653 | Jun 05, 2017, 07:25 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jun 01, 2017 | Option Exercise | $0.52 | 77,971 | 40,545 | 117,871 | Jun 05, 2017, 07:25 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jun 02, 2017 | Sale | $10.10 | 48,753 | 492,283 | 39,900 | Jun 05, 2017, 07:25 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jun 01, 2017 | Sale | $10.00 | 77,971 | 779,866 | 39,900 | Jun 05, 2017, 07:25 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jun 05, 2017 | Sale | $9.99 | 17,577 | 175,628 | 39,900 | Jun 05, 2017, 07:25 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Jun 01, 2017 | Option Exercise | $0.52 | 8,000 | 4,160 | 57,300 | Jun 05, 2017, 07:22 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Jun 01, 2017 | Sale | $10.00 | 8,000 | 80,020 | 49,300 | Jun 05, 2017, 07:22 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | May 17, 2017 | Sale | $9.65 | 1,011 | 9,756 | 49,300 | May 18, 2017, 08:33 PM |
| Templeman Blaine | Executive VP, General Counsel | May 17, 2017 | Sale | $9.65 | 1,648 | 15,903 | 37,300 | May 18, 2017, 08:30 PM |
| ISAACS STEPHEN T | President and CEO | May 16, 2017 | Option Exercise | $0.52 | 16,673 | 8,670 | 120,698 | May 17, 2017, 05:55 PM |
| ISAACS STEPHEN T | President and CEO | May 15, 2017 | Option Exercise | $0.52 | 10,600 | 5,512 | 114,625 | May 17, 2017, 05:55 PM |
| ISAACS STEPHEN T | President and CEO | May 16, 2017 | Sale | $10.00 | 16,673 | 166,797 | 104,025 | May 17, 2017, 05:55 PM |
| ISAACS STEPHEN T | President and CEO | May 15, 2017 | Sale | $10.01 | 10,600 | 106,154 | 104,025 | May 17, 2017, 05:55 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | May 11, 2017 | Option Exercise | $0.52 | 8,000 | 4,160 | 57,300 | May 15, 2017, 06:57 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | May 11, 2017 | Sale | $9.72 | 8,000 | 77,725 | 49,300 | May 15, 2017, 06:57 PM |
| Dubensky Thomas W. | Chief Scientific Officer | May 12, 2017 | Option Exercise | $0.52 | 4,299 | 2,235 | 44,199 | May 15, 2017, 06:56 PM |
| Dubensky Thomas W. | Chief Scientific Officer | May 11, 2017 | Option Exercise | $0.52 | 1,400 | 728 | 41,300 | May 15, 2017, 06:56 PM |
| Dubensky Thomas W. | Chief Scientific Officer | May 12, 2017 | Sale | $9.92 | 4,299 | 42,658 | 39,900 | May 15, 2017, 06:56 PM |
| Dubensky Thomas W. | Chief Scientific Officer | May 11, 2017 | Sale | $9.91 | 1,400 | 13,870 | 39,900 | May 15, 2017, 06:56 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Apr 03, 2017 | Option Exercise | $0.45 | 8,000 | 3,600 | 57,300 | Apr 04, 2017, 08:18 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Apr 03, 2017 | Sale | $10.71 | 8,000 | 85,645 | 49,300 | Apr 04, 2017, 08:18 PM |
| ISAACS STEPHEN T | President and CEO | Apr 03, 2017 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Apr 04, 2017, 08:17 PM |
| ISAACS STEPHEN T | President and CEO | Apr 03, 2017 | Sale | $10.28 | 27,273 | 280,429 | 102,200 | Apr 04, 2017, 08:17 PM |
| ISAACS STEPHEN T | President and CEO | Mar 13, 2017 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Mar 14, 2017, 08:02 PM |
| ISAACS STEPHEN T | President and CEO | Mar 13, 2017 | Sale | $11.35 | 27,273 | 309,434 | 102,200 | Mar 14, 2017, 08:02 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Mar 09, 2017 | Option Exercise | $0.45 | 8,000 | 3,600 | 57,300 | Mar 10, 2017, 08:05 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Mar 09, 2017 | Sale | $11.00 | 8,000 | 88,001 | 49,300 | Mar 10, 2017, 08:05 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Mar 09, 2017 | Option Exercise | $0.78 | 25,000 | 19,446 | 64,900 | Mar 10, 2017, 08:04 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Mar 09, 2017 | Sale | $10.96 | 25,000 | 274,078 | 39,900 | Mar 10, 2017, 08:04 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Jan 17, 2017 | Option Exercise | $0.45 | 8,000 | 3,600 | 57,300 | Jan 19, 2017, 06:52 PM |
| Brockstedt Dirk G. | EVP of Research and Dev. | Jan 17, 2017 | Sale | $11.86 | 8,000 | 94,858 | 49,300 | Jan 19, 2017, 06:52 PM |
| Templeman Blaine | Executive VP, General Counsel | Jan 11, 2017 | Sale | $11.95 | 3,785 | 45,231 | 37,300 | Jan 13, 2017, 04:33 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jan 03, 2017 | Option Exercise | $0.52 | 25,000 | 13,000 | 64,900 | Jan 05, 2017, 05:15 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jan 03, 2017 | Sale | $11.16 | 25,000 | 278,990 | 39,900 | Jan 05, 2017, 05:15 PM |
| ISAACS STEPHEN T | President and CEO | Jan 03, 2017 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Jan 05, 2017, 05:14 PM |
| ISAACS STEPHEN T | President and CEO | Jan 03, 2017 | Sale | $11.12 | 27,273 | 303,289 | 102,200 | Jan 05, 2017, 05:14 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Dec 23, 2016 | Option Exercise | $0.82 | 35,000 | 28,700 | 120,979 | Dec 27, 2016, 09:12 AM |
| ISAACS STEPHEN T | President and CEO | Dec 01, 2016 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Dec 05, 2016, 07:23 PM |
| ISAACS STEPHEN T | President and CEO | Dec 01, 2016 | Sale | $10.82 | 27,273 | 295,169 | 102,300 | Dec 05, 2016, 07:23 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2016 | Option Exercise | $1.04 | 25,000 | 25,893 | 64,900 | Dec 05, 2016, 07:21 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2016 | Sale | $10.94 | 25,000 | 273,500 | 39,900 | Dec 05, 2016, 07:21 PM |
| Haghighat Ross | Director | Nov 14, 2016 | Sale | $15.50 | 7,088 | 109,864 | 81,880 | Nov 16, 2016, 09:19 PM |
| ISAACS STEPHEN T | President and CEO | Nov 14, 2016 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Nov 16, 2016, 05:06 PM |
| ISAACS STEPHEN T | President and CEO | Nov 14, 2016 | Sale | $15.26 | 27,273 | 416,050 | 102,200 | Nov 16, 2016, 05:06 PM |
| Lew Jennifer | Sr. Vice President of Finance | Nov 10, 2016 | Option Exercise | $0.82 | 10,910 | 8,946 | 53,505 | Nov 14, 2016, 07:02 PM |
| Lew Jennifer | Sr. Vice President of Finance | Nov 10, 2016 | Sale | $14.95 | 10,910 | 163,104 | 42,595 | Nov 14, 2016, 07:02 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 11, 2016 | Option Exercise | $1.45 | 30,144 | 43,709 | 116,123 | Nov 14, 2016, 07:01 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 10, 2016 | Option Exercise | $1.45 | 49,856 | 72,291 | 135,835 | Nov 14, 2016, 07:01 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 10, 2016 | Sale | $14.74 | 49,856 | 734,698 | 85,979 | Nov 14, 2016, 07:01 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 11, 2016 | Sale | $14.86 | 30,144 | 448,033 | 85,979 | Nov 14, 2016, 07:01 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Nov 10, 2016 | Option Exercise | $1.30 | 25,000 | 32,588 | 64,900 | Nov 14, 2016, 07:00 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Nov 10, 2016 | Sale | $14.78 | 25,000 | 369,408 | 39,900 | Nov 14, 2016, 07:00 PM |
| ISAACS STEPHEN T | President and CEO | Oct 03, 2016 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Oct 05, 2016, 05:22 PM |
| ISAACS STEPHEN T | President and CEO | Oct 03, 2016 | Sale | $12.67 | 27,273 | 345,522 | 102,200 | Oct 05, 2016, 05:22 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Oct 03, 2016 | Option Exercise | $1.10 | 25,000 | 27,437 | 64,900 | Oct 05, 2016, 05:18 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Oct 03, 2016 | Sale | $12.68 | 25,000 | 316,908 | 39,900 | Oct 05, 2016, 05:18 PM |
| Lew Jennifer | Sr. Vice President of Finance | Sep 19, 2016 | Option Exercise | $0.82 | 5,455 | 4,473 | 48,955 | Sep 21, 2016, 04:57 PM |
| Lew Jennifer | Sr. Vice President of Finance | Sep 19, 2016 | Sale | $14.95 | 6,360 | 95,082 | 42,595 | Sep 21, 2016, 04:57 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Sep 01, 2016 | Option Exercise | $1.13 | 25,000 | 28,259 | 25,000 | Sep 02, 2016, 04:24 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Sep 01, 2016 | Sale | $14.03 | 25,000 | 350,775 | 0 | Sep 02, 2016, 04:24 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2016 | Option Exercise | $0.99 | 25,000 | 24,625 | 25,000 | Aug 12, 2016, 05:43 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2016 | Sale | $15.18 | 25,000 | 379,500 | 0 | Aug 12, 2016, 05:43 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2016 | Option Exercise | $1.04 | 25,000 | 25,963 | 25,000 | Jul 07, 2016, 06:38 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2016 | Sale | $11.61 | 25,000 | 290,250 | 0 | Jul 07, 2016, 06:38 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | May 16, 2016 | Sale | $8.20 | 905 | 7,421 | 12,000 | May 18, 2016, 07:14 PM |
| SCHAFER GREGORY W | Chief Operating Officer | May 16, 2016 | Sale | $8.20 | 905 | 7,421 | 49,279 | May 18, 2016, 07:13 PM |
| Dubensky Thomas W. | Chief Scientific Officer | May 16, 2016 | Sale | $8.20 | 905 | 7,421 | 0 | May 18, 2016, 07:11 PM |
| Morningside Venture (VI) Investments Ltd | 10% Owner | Feb 18, 2016 | Option Exercise | $0.10 | 762,014 | 76,097 | 19,805,532 | Feb 22, 2016, 05:59 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Jan 11, 2016 | Option Exercise | $0.49 | 22,000 | 10,856 | 33,044 | Jan 11, 2016, 08:35 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Jan 11, 2016 | Sale | $21.77 | 22,000 | 479,015 | 14,406 | Jan 11, 2016, 08:35 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jan 08, 2016 | Option Exercise | $1.00 | 20,000 | 20,000 | 69,279 | Jan 11, 2016, 08:33 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Jan 08, 2016 | Sale | $23.58 | 20,000 | 471,600 | 49,279 | Jan 11, 2016, 08:33 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jan 04, 2016 | Option Exercise | $4.68 | 15,000 | 70,158 | 15,000 | Jan 06, 2016, 06:18 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Jan 04, 2016 | Sale | $26.37 | 15,000 | 395,531 | 3,771 | Jan 06, 2016, 06:18 PM |
| ISAACS STEPHEN T | President and CEO | Jan 05, 2016 | Option Exercise | $0.52 | 12,500 | 6,500 | 22,500 | Jan 06, 2016, 06:16 PM |
| ISAACS STEPHEN T | President and CEO | Jan 04, 2016 | Option Exercise | $0.52 | 12,500 | 6,500 | 22,500 | Jan 06, 2016, 06:16 PM |
| ISAACS STEPHEN T | President and CEO | Jan 05, 2016 | Sale | $26.26 | 12,500 | 328,196 | 10,906 | Jan 06, 2016, 06:16 PM |
| ISAACS STEPHEN T | President and CEO | Jan 04, 2016 | Sale | $26.37 | 12,500 | 329,603 | 10,300 | Jan 06, 2016, 06:16 PM |
| Lew Jennifer | Sr. Vice President of Finance | Jan 06, 2016 | Option Exercise | $0.82 | 5,242 | 4,298 | 11,442 | Jan 06, 2016, 06:13 PM |
| Lew Jennifer | Sr. Vice President of Finance | Jan 06, 2016 | Sale | $25.71 | 5,242 | 134,765 | 7,000 | Jan 06, 2016, 06:13 PM |
| ISAACS STEPHEN T | President and CEO | Dec 31, 2015 | Option Exercise | $0.45 | 10,000 | 4,500 | 10,000 | Jan 04, 2016, 07:04 PM |
| Lew Jennifer | Sr. Vice President of Finance | Dec 29, 2015 | Option Exercise | $0.82 | 4,200 | 3,444 | 6,200 | Dec 29, 2015, 06:11 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Dec 24, 2015 | Option Exercise | $0.82 | 15,000 | 12,300 | 49,279 | Dec 28, 2015, 07:22 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Dec 16, 2015 | Option Exercise | $1.45 | 12,000 | 17,400 | 12,000 | Dec 17, 2015, 07:06 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Dec 10, 2015 | Option Exercise | $1.45 | 25,000 | 36,250 | 25,000 | Dec 14, 2015, 06:42 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Dec 10, 2015 | Sale | $29.82 | 25,000 | 745,423 | 19,265 | Dec 14, 2015, 06:42 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Dec 07, 2015 | Option Exercise | $1.45 | 25,000 | 36,250 | 59,279 | Dec 07, 2015, 07:40 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Dec 07, 2015 | Sale | $29.74 | 25,000 | 743,571 | 42,579 | Dec 07, 2015, 07:40 PM |
| Lew Jennifer | Sr. Vice President of Finance | Dec 03, 2015 | Option Exercise | $0.82 | 5,242 | 4,298 | 7,242 | Dec 07, 2015, 07:32 PM |
| Lew Jennifer | Sr. Vice President of Finance | Dec 03, 2015 | Sale | $29.85 | 5,242 | 156,486 | 2,100 | Dec 07, 2015, 07:32 PM |
| ISAACS STEPHEN T | President and CEO | Dec 01, 2015 | Option Exercise | $0.52 | 25,000 | 13,000 | 25,000 | Dec 02, 2015, 06:26 PM |
| ISAACS STEPHEN T | President and CEO | Dec 01, 2015 | Sale | $29.11 | 25,000 | 727,664 | 2,200 | Dec 02, 2015, 06:26 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2015 | Option Exercise | $2.15 | 30,000 | 64,373 | 30,000 | Dec 02, 2015, 06:24 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2015 | Sale | $29.27 | 30,000 | 878,104 | 9,626 | Dec 02, 2015, 06:24 PM |
| Greenman William Mariner | Director | Nov 30, 2015 | Sale | $30.65 | 3,000 | 91,950 | 0 | Dec 02, 2015, 06:21 PM |
| Lew Jennifer | Sr. Vice President of Finance | Nov 18, 2015 | Option Exercise | $0.82 | 5,242 | 4,298 | 8,712 | Nov 18, 2015, 08:30 PM |
| Lew Jennifer | Sr. Vice President of Finance | Nov 18, 2015 | Sale | $28.52 | 6,712 | 191,426 | 3,470 | Nov 18, 2015, 08:30 PM |
| ISAACS STEPHEN T | President and CEO | Nov 16, 2015 | Option Exercise | $0.52 | 25,000 | 13,000 | 25,000 | Nov 18, 2015, 08:27 PM |
| ISAACS STEPHEN T | President and CEO | Nov 16, 2015 | Sale | $27.54 | 25,000 | 688,490 | 2,700 | Nov 18, 2015, 08:27 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 17, 2015 | Option Exercise | $0.69 | 19,047 | 13,220 | 19,047 | Nov 18, 2015, 08:24 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 16, 2015 | Option Exercise | $0.45 | 5,953 | 2,679 | 7,423 | Nov 18, 2015, 08:24 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 17, 2015 | Sale | $28.65 | 19,047 | 545,734 | 16,947 | Nov 18, 2015, 08:24 PM |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 16, 2015 | Sale | $27.52 | 7,423 | 204,294 | 1,470 | Nov 18, 2015, 08:24 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 16, 2015 | Option Exercise | $1.45 | 9,822 | 14,242 | 45,571 | Nov 18, 2015, 08:21 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 17, 2015 | Option Exercise | $1.45 | 15,178 | 22,008 | 49,457 | Nov 18, 2015, 08:21 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 17, 2015 | Sale | $28.60 | 15,178 | 434,072 | 46,849 | Nov 18, 2015, 08:21 PM |
| SCHAFER GREGORY W | Chief Operating Officer | Nov 16, 2015 | Sale | $27.56 | 11,292 | 311,168 | 36,349 | Nov 18, 2015, 08:21 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Nov 17, 2015 | Option Exercise | $1.45 | 20,519 | 29,753 | 20,519 | Nov 18, 2015, 08:11 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Nov 16, 2015 | Option Exercise | $1.45 | 9,481 | 13,747 | 10,951 | Nov 18, 2015, 08:11 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Nov 17, 2015 | Sale | $28.65 | 20,519 | 587,822 | 18,520 | Nov 18, 2015, 08:11 PM |
| Dubensky Thomas W. | Chief Scientific Officer | Nov 16, 2015 | Sale | $27.55 | 10,951 | 301,733 | 2,170 | Nov 18, 2015, 08:11 PM |
| ISAACS STEPHEN T | President and CEO | Jul 24, 2015 | Option Exercise | $0.05 | 11,916 | 609 | 154,687 | Jul 27, 2015, 06:51 PM |
| Rogers John E. and Lois A. | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 7,500 | 127,500 | 33,649 | Apr 22, 2015, 05:50 PM |
| Rogers John E. and Lois A. | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 10,000 | 170,000 | 36,149 | Apr 22, 2015, 05:50 PM |
| Rogers John E. and Lois A. | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 147,058 | 2,499,986 | 5,991,759 | Apr 22, 2015, 05:49 PM |
| Morningside Venture (VI) Investments Ltd | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 441,176 | 7,499,992 | 19,043,518 | Apr 22, 2015, 05:46 PM |
| OBrien Stephanie Monaghan | Director | Apr 20, 2015 | Buy | $17.00 | 1,700 | 28,900 | 1,700 | Apr 22, 2015, 05:45 PM |
| OBrien Stephanie Monaghan | Director | Apr 20, 2015 | Buy | $17.00 | 1,700 | 28,900 | 1,700 | Apr 22, 2015, 05:45 PM |
| Greenman William Mariner | Director | Apr 20, 2015 | Buy | $17.00 | 3,000 | 51,000 | 3,000 | Apr 22, 2015, 05:43 PM |
| Lew Jennifer | Sr. Vice President of Finance | Apr 20, 2015 | Buy | $17.00 | 2,000 | 34,000 | 2,000 | Apr 22, 2015, 05:41 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| King Andrew James | Chief Scientific Officer | 08/01/2023 | 45,586 |
| Greenman William Mariner | Director | 05/30/2023 | 26,911 |
| DOBMEIER ERIC | President, CEO | 04/24/2023 | 10,500 |
| DOBMEIER ERIC | President, CEO | 04/24/2023 | 540,239 |
| Jerel Davis | Director | 04/17/2023 | 6,138,223 |
| King Andrew James | Chief Scientific Officer | 04/03/2023 | 875 |
| King Andrew James | Chief Scientific Officer | 04/03/2023 | 116,718 |
| Krishnan Mahesh | Director | 04/04/2023 | 21,261 |
| Jerel Davis | Director | 03/01/2023 | 9,100,000 |
| BJERKHOLT ERIC | Chief Financial Officer | 02/10/2023 | 20,352 |
| DOBMEIER ERIC | President, CEO | 02/10/2023 | 192,292 |
| Frohlich Tom | Chief Operating Officer | 02/10/2023 | 87,869 |
| King Andrew James | Chief Scientific Officer | 02/10/2023 | 56,806 |
| Frohlich Tom | Chief Operating Officer | 01/31/2023 | 112,700 |
| BJERKHOLT ERIC | Chief Financial Officer | 01/31/2023 | 71,357 |
| King Andrew James | Chief Scientific Officer | 01/31/2023 | 80,069 |
| DOBMEIER ERIC | President, CEO | 01/30/2023 | 10,500 |
| DOBMEIER ERIC | President, CEO | 01/31/2023 | 189,757 |
| DOBMEIER ERIC | President, CEO | 01/30/2023 | 613,613 |
| King Andrew James | Chief Scientific Officer | 01/03/2023 | 2,625 |
| King Andrew James | Chief Scientific Officer | 01/03/2023 | 258,183 |
| Frohlich Tom | Chief Operating Officer | 12/13/2022 | 4,200 |
| Frohlich Tom | Chief Operating Officer | 12/13/2022 | 250,005 |
| DOBMEIER ERIC | President, CEO | 12/14/2022 | 10,500 |
| DOBMEIER ERIC | President, CEO | 12/01/2022 | 25,200 |
| DOBMEIER ERIC | President, CEO | 12/01/2022 | 669,351 |
| BJERKHOLT ERIC | Chief Financial Officer | 12/01/2022 | 128,602 |
| Frohlich Tom | Chief Operating Officer | 11/07/2022 | 4,200 |
| Frohlich Tom | Chief Operating Officer | 11/07/2022 | 221,642 |
| Frohlich Tom | Chief Operating Officer | 10/06/2022 | 144,933 |
| King Andrew James | Chief Scientific Officer | 10/06/2022 | 70,044 |
| Thomas Dolca | Director | 09/02/2022 | 212,194 |
| King Andrew James | Chief Scientific Officer | 08/04/2022 | 1,750 |
| King Andrew James | Chief Scientific Officer | 08/04/2022 | 100,000 |
| King Andrew James | Chief Scientific Officer | 07/11/2022 | 1,750 |
| King Andrew James | Chief Scientific Officer | 07/11/2022 | 90,468 |
| AKKARAJU SRINIVAS | Director | 05/27/2022 | 7,980,000 |
| DOBMEIER ERIC | President, CEO | 05/25/2022 | 65,148 |
| King Andrew James | Chief Scientific Officer | 04/11/2022 | 1,750 |
| King Andrew James | Chief Scientific Officer | 04/11/2022 | 76,812 |
| King Andrew James | Chief Scientific Officer | 02/18/2022 | 32,500 |
| BJERKHOLT ERIC | Chief Financial Officer | 02/11/2022 | 11,403 |
| King Andrew James | Chief Scientific Officer | 02/11/2022 | 31,827 |
| Glicklich Alan | Chief Medical Officer | 02/11/2022 | 30,464 |
| Frohlich Tom | Chief Operating Officer | 02/11/2022 | 47,587 |
| King Andrew James | Chief Scientific Officer | 02/10/2022 | 875 |
| King Andrew James | Chief Scientific Officer | 02/10/2022 | 33,275 |
| Versant Venture Capital VII, L.P. | 10% Owner | 01/03/2022 | 6,400,080 |
| Versant Venture Capital VII, L.P. | 10% Owner | 01/03/2022 | 9,600,120 |
| Jerel Davis | Director | 01/03/2022 | 16,000,200 |
| DOBMEIER ERIC | President, CEO | 12/23/2021 | 14,000 |
| BJERKHOLT ERIC | Chief Financial Officer | 12/01/2021 | 92,097 |
| AKKARAJU SRINIVAS | Director | 11/15/2021 | 17,010,000 |
| Frohlich Tom | Chief Operating Officer | 11/10/2021 | 96,440 |
| King Andrew James | Chief Scientific Officer | 11/09/2021 | 875 |
| King Andrew James | Chief Scientific Officer | 11/09/2021 | 67,660 |
| Frohlich Tom | Chief Operating Officer | 11/05/2021 | 6,300 |
| Frohlich Tom | Chief Operating Officer | 11/08/2021 | 208,938 |
| Frohlich Tom | Chief Operating Officer | 11/05/2021 | 280,000 |
| Greenman William Mariner | Director | 10/21/2021 | 4,324 |
| Frohlich Tom | Chief Operating Officer | 10/06/2021 | 91,021 |
| King Andrew James | Chief Scientific Officer | 10/06/2021 | 43,995 |
| Glicklich Alan | Chief Medical Officer | 10/06/2021 | 30,785 |
| Frohlich Tom | Chief Operating Officer | 09/24/2021 | 8,400 |
| Frohlich Tom | Chief Operating Officer | 09/24/2021 | 260,000 |
| DOBMEIER ERIC | President, CEO | 09/20/2021 | 24,000 |
| Jerel Davis | Director | 08/27/2021 | 11,900,000 |
| Versant Venture Capital VII, L.P. | 10% Owner | 08/27/2021 | 4,760,000 |
| Versant Venture Capital VII, L.P. | 10% Owner | 08/27/2021 | 7,140,000 |
| AKKARAJU SRINIVAS | Director | 08/18/2021 | 2,497,830 |
| DOBMEIER ERIC | President, CEO | 08/18/2021 | 82,163 |
| DOBMEIER ERIC | President, CEO | 08/19/2021 | 36,000 |
| Glicklich Alan | Chief Medical Officer | 06/16/2021 | 8,400 |
| Glicklich Alan | Chief Medical Officer | 06/16/2021 | 326,968 |
| DOBMEIER ERIC | President, CEO | 06/14/2021 | 7,000 |
| DOBMEIER ERIC | President, CEO | 12/21/2020 | 7,000 |
| DOBMEIER ERIC | President, CEO | 12/08/2020 | 26,483 |
| DOBMEIER ERIC | President, CEO | 12/09/2020 | 26,150 |
| DOBMEIER ERIC | President, CEO | 11/23/2020 | 12,699 |
| DOBMEIER ERIC | President, CEO | 11/20/2020 | 7,817 |
| DOBMEIER ERIC | President, CEO | 11/19/2020 | 6,750 |
| DOBMEIER ERIC | President, CEO | 11/11/2020 | 34,375 |
| DOBMEIER ERIC | President, CEO | 11/10/2020 | 27,720 |
| ISAACS STEPHEN T | President and CEO | 09/15/2020 | 77,691 |
| Templeman Blaine | Chief Legal Officer | 09/15/2020 | 29,585 |
| Ferber Celeste | SVP, GC and Secretary | 09/15/2020 | 5,731 |
| Nuyten Dimitry SA | Chief Medical Officer | 08/07/2020 | 9,036 |
| Templeman Blaine | Chief Legal Officer | 08/07/2020 | 20,308 |
| Ferber Celeste | SVP, GC and Secretary | 08/07/2020 | 20,308 |
| Greenman William Mariner | Director | 03/18/2020 | 8,926 |
| ISAACS STEPHEN T | President and CEO | 03/18/2020 | 9,728 |
| van Elsas Andrea | Chief Scientific Officer | 02/25/2020 | 23,954 |
| van Elsas Andrea | Chief Scientific Officer | 01/03/2020 | 87,108 |
| Templeman Blaine | Chief Legal Officer | 12/12/2019 | 1,470 |
| Ferber Celeste | SVP, GC and Secretary | 12/12/2019 | 475 |
| van Elsas Andrea | Chief Scientific Officer | 12/12/2019 | 2,550 |
| ISAACS STEPHEN T | President and CEO | 12/12/2019 | 6,860 |
| Haghighat Ross | Director | 09/16/2019 | 35,527 |
| Ferber Celeste | SVP, GC and Secretary | 09/13/2019 | 3,257 |
| ISAACS STEPHEN T | President and CEO | 09/13/2019 | 40,608 |
| van Elsas Andrea | Chief Scientific Officer | 09/13/2019 | 24,279 |
| Templeman Blaine | Chief Legal Officer | 09/13/2019 | 16,817 |
| Ferber Celeste | SVP, GC and Secretary | 05/20/2019 | 6,413 |
| Lew Jennifer | Chief Financial Officer | 05/01/2019 | 23,306 |
| Lew Jennifer | Chief Financial Officer | 05/01/2019 | 78,136 |
| Lew Jennifer | Chief Financial Officer | 04/08/2019 | 23,305 |
| Lew Jennifer | Chief Financial Officer | 04/08/2019 | 75,775 |
| van Elsas Andrea | Chief Scientific Officer | 03/19/2019 | 24,107 |
| van Elsas Andrea | Chief Scientific Officer | 02/26/2019 | 29,120 |
| van Elsas Andrea | Chief Scientific Officer | 12/28/2018 | 4,901 |
| Lew Jennifer | Chief Financial Officer | 12/12/2018 | 3,035 |
| Templeman Blaine | Chief Legal Officer | 12/12/2018 | 3,639 |
| ISAACS STEPHEN T | President and CEO | 12/12/2018 | 17,091 |
| van Elsas Andrea | Chief Scientific Officer | 12/12/2018 | 6,365 |
| Templeman Blaine | Chief Legal Officer | 11/20/2018 | 2,453 |
| van Elsas Andrea | Chief Scientific Officer | 09/24/2018 | 45,022 |
| Templeman Blaine | Chief Legal Officer | 09/24/2018 | 59,613 |
| Templeman Blaine | Executive VP, General Counsel | 09/13/2018 | 39,360 |
| van Elsas Andrea | Chief Scientific Officer | 09/13/2018 | 63,394 |
| Lew Jennifer | Chief Financial Officer | 09/13/2018 | 36,546 |
| Sacks Natalie | Chief Medical Officer | 09/13/2018 | 19,680 |
| ISAACS STEPHEN T | President and CEO | 09/13/2018 | 156,913 |
| ISAACS STEPHEN T | President and CEO | 09/06/2018 | 46,987 |
| ISAACS STEPHEN T | President and CEO | 09/05/2018 | 15,585 |
| ISAACS STEPHEN T | President and CEO | 09/05/2018 | 123,134 |
| ISAACS STEPHEN T | President and CEO | 09/06/2018 | 372,024 |
| Sacks Natalie | Chief Medical Officer | 09/04/2018 | 32,099 |
| van Elsas Andrea | Chief Scientific Officer | 07/17/2018 | 72,803 |
| ISAACS STEPHEN T | President and CEO | 06/01/2018 | 40,000 |
| ISAACS STEPHEN T | President and CEO | 06/01/2018 | 347,004 |
| Templeman Blaine | Chief Legal Officer | 05/17/2018 | 16,300 |
| ISAACS STEPHEN T | President and CEO | 05/09/2018 | 38,976 |
| ISAACS STEPHEN T | President and CEO | 05/09/2018 | 320,348 |
| ISAACS STEPHEN T | President and CEO | 04/02/2018 | 32,800 |
| ISAACS STEPHEN T | President and CEO | 04/02/2018 | 356,400 |
| ISAACS STEPHEN T | President and CEO | 03/09/2018 | 23,165 |
| ISAACS STEPHEN T | President and CEO | 03/08/2018 | 11,535 |
| ISAACS STEPHEN T | President and CEO | 03/09/2018 | 407,268 |
| ISAACS STEPHEN T | President and CEO | 03/08/2018 | 203,790 |
| van Elsas Andrea | Chief Scientific Officer | 02/26/2018 | 44,522 |
| SCHAFER GREGORY W | Chief Operating Officer | 01/25/2018 | 49,200 |
| SCHAFER GREGORY W | Chief Operating Officer | 01/25/2018 | 33 |
| ISAACS STEPHEN T | President and CEO | 01/05/2018 | 3,577 |
| ISAACS STEPHEN T | President and CEO | 01/05/2018 | 63,195 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 12/29/2017 | 75,400 |
| SCHAFER GREGORY W | Chief Operating Officer | 01/02/2018 | 20,767 |
| SCHAFER GREGORY W | Chief Operating Officer | 12/29/2017 | 34,440 |
| SCHAFER GREGORY W | Chief Operating Officer | 01/02/2018 | 152,142 |
| Templeman Blaine | Executive VP, General Counsel | 12/18/2017 | 23,793 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 12/15/2017 | 92,957 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 12/15/2017 | 529,187 |
| van Elsas Andrea | Chief Scientific Officer | 09/13/2017 | 54,072 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 12/01/2017 | 5,200 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 12/01/2017 | 93,998 |
| Lew Jennifer | Sr. Vice President of Finance | 12/01/2017 | 5,412 |
| Lew Jennifer | Sr. Vice President of Finance | 12/01/2017 | 62,433 |
| SCHAFER GREGORY W | Chief Operating Officer | 12/01/2017 | 20,767 |
| SCHAFER GREGORY W | Chief Operating Officer | 12/01/2017 | 186,882 |
| ISAACS STEPHEN T | President and CEO | 12/01/2017 | 18,000 |
| ISAACS STEPHEN T | President and CEO | 12/01/2017 | 375,028 |
| Templeman Blaine | Executive VP, General Counsel | 11/17/2017 | 2,151 |
| Lew Jennifer | Sr. Vice President of Finance | 11/15/2017 | 5,412 |
| Lew Jennifer | Sr. Vice President of Finance | 11/15/2017 | 59,070 |
| ISAACS STEPHEN T | President and CEO | 11/13/2017 | 1,530 |
| ISAACS STEPHEN T | President and CEO | 11/10/2017 | 7,380 |
| ISAACS STEPHEN T | President and CEO | 11/13/2017 | 27,215 |
| ISAACS STEPHEN T | President and CEO | 11/10/2017 | 130,508 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 11/13/2017 | 2,112 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 11/10/2017 | 944 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 11/10/2017 | 14,544 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 11/13/2017 | 32,496 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/06/2017 | 20,767 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/06/2017 | 159,312 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 11/06/2017 | 2,144 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 11/06/2017 | 33,132 |
| ISAACS STEPHEN T | President and CEO | 11/07/2017 | 1,710 |
| ISAACS STEPHEN T | President and CEO | 11/06/2017 | 7,380 |
| ISAACS STEPHEN T | President and CEO | 11/07/2017 | 30,223 |
| ISAACS STEPHEN T | President and CEO | 11/06/2017 | 130,934 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 10/02/2017 | 5,200 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 10/02/2017 | 105,870 |
| SCHAFER GREGORY W | Chief Operating Officer | 10/02/2017 | 27,148 |
| SCHAFER GREGORY W | Chief Operating Officer | 10/02/2017 | 215,060 |
| ISAACS STEPHEN T | President and CEO | 10/02/2017 | 18,000 |
| ISAACS STEPHEN T | President and CEO | 10/02/2017 | 431,032 |
| Lew Jennifer | Sr. Vice President of Finance | 10/02/2017 | 5,412 |
| Lew Jennifer | Sr. Vice President of Finance | 10/02/2017 | 69,995 |
| Templeman Blaine | Executive VP, General Counsel | 09/18/2017 | 32,301 |
| ISAACS STEPHEN T | President and CEO | 09/13/2017 | 134,071 |
| SCHAFER GREGORY W | Chief Operating Officer | 09/13/2017 | 53,380 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 09/13/2017 | 39,076 |
| Lew Jennifer | Sr. Vice President of Finance | 09/13/2017 | 39,076 |
| van Elsas Andrea | Chief Scientific Officer | 09/13/2017 | 54,072 |
| Templeman Blaine | Executive VP, General Counsel | 09/13/2017 | 39,076 |
| Sacks Natalie | Chief Medical Officer | 09/01/2017 | 57,196 |
| SCHAFER GREGORY W | Chief Operating Officer | 09/01/2017 | 24,800 |
| SCHAFER GREGORY W | Chief Operating Officer | 09/01/2017 | 233,980 |
| Lew Jennifer | Sr. Vice President of Finance | 09/01/2017 | 5,412 |
| Lew Jennifer | Sr. Vice President of Finance | 09/01/2017 | 77,242 |
| ISAACS STEPHEN T | President and CEO | 09/01/2017 | 18,000 |
| ISAACS STEPHEN T | President and CEO | 09/01/2017 | 468,596 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 09/01/2017 | 5,200 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 09/01/2017 | 116,948 |
| Dubensky Thomas W. | Chief Scientific Officer | 08/11/2017 | 9,088 |
| Dubensky Thomas W. | Chief Scientific Officer | 08/10/2017 | 40,912 |
| Dubensky Thomas W. | Chief Scientific Officer | 08/11/2017 | 101,538 |
| Dubensky Thomas W. | Chief Scientific Officer | 08/10/2017 | 467,665 |
| ISAACS STEPHEN T | President and CEO | 08/07/2017 | 18,000 |
| ISAACS STEPHEN T | President and CEO | 08/07/2017 | 487,564 |
| SCHAFER GREGORY W | Chief Operating Officer | 08/08/2017 | 18,004 |
| SCHAFER GREGORY W | Chief Operating Officer | 08/07/2017 | 31,616 |
| SCHAFER GREGORY W | Chief Operating Officer | 08/08/2017 | 172,550 |
| SCHAFER GREGORY W | Chief Operating Officer | 08/07/2017 | 314,233 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 08/07/2017 | 5,200 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 08/07/2017 | 121,795 |
| Lew Jennifer | Sr. Vice President of Finance | 08/07/2017 | 5,412 |
| Lew Jennifer | Sr. Vice President of Finance | 08/07/2017 | 80,290 |
| Lew Jennifer | Sr. Vice President of Finance | 07/03/2017 | 9,840 |
| Lew Jennifer | Sr. Vice President of Finance | 07/03/2017 | 133,632 |
| ISAACS STEPHEN T | President and CEO | 07/03/2017 | 19,965 |
| ISAACS STEPHEN T | President and CEO | 07/03/2017 | 427,634 |
| ISAACS STEPHEN T | President and CEO | 07/05/2017 | 14,763 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 07/03/2017 | 4,826 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 07/03/2017 | 110,167 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/05/2017 | 17,518 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/03/2017 | 6,136 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/06/2017 | 2,346 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/05/2017 | 385,936 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/03/2017 | 130,028 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/06/2017 | 50,673 |
| Lew Jennifer | Sr. Vice President of Finance | 06/28/2017 | 9,840 |
| Lew Jennifer | Sr. Vice President of Finance | 06/28/2017 | 134,236 |
| SCHAFER GREGORY W | Chief Operating Officer | 06/28/2017 | 58,000 |
| SCHAFER GREGORY W | Chief Operating Officer | 06/28/2017 | 450,568 |
| ISAACS STEPHEN T | President and CEO | 06/19/2017 | 20,800 |
| ISAACS STEPHEN T | President and CEO | 06/19/2017 | 420,164 |
| Dubensky Thomas W. | Chief Scientific Officer | 06/05/2017 | 9,140 |
| Dubensky Thomas W. | Chief Scientific Officer | 06/02/2017 | 25,352 |
| Dubensky Thomas W. | Chief Scientific Officer | 06/01/2017 | 40,545 |
| Dubensky Thomas W. | Chief Scientific Officer | 06/02/2017 | 492,283 |
| Dubensky Thomas W. | Chief Scientific Officer | 06/01/2017 | 779,866 |
| Dubensky Thomas W. | Chief Scientific Officer | 06/05/2017 | 175,628 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 06/01/2017 | 4,160 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 06/01/2017 | 80,020 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 05/17/2017 | 9,756 |
| Templeman Blaine | Executive VP, General Counsel | 05/17/2017 | 15,903 |
| ISAACS STEPHEN T | President and CEO | 05/16/2017 | 8,670 |
| ISAACS STEPHEN T | President and CEO | 05/15/2017 | 5,512 |
| ISAACS STEPHEN T | President and CEO | 05/16/2017 | 166,797 |
| ISAACS STEPHEN T | President and CEO | 05/15/2017 | 106,154 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 05/11/2017 | 4,160 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 05/11/2017 | 77,725 |
| Dubensky Thomas W. | Chief Scientific Officer | 05/12/2017 | 2,235 |
| Dubensky Thomas W. | Chief Scientific Officer | 05/11/2017 | 728 |
| Dubensky Thomas W. | Chief Scientific Officer | 05/12/2017 | 42,658 |
| Dubensky Thomas W. | Chief Scientific Officer | 05/11/2017 | 13,870 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 04/03/2017 | 3,600 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 04/03/2017 | 85,645 |
| ISAACS STEPHEN T | President and CEO | 04/03/2017 | 14,182 |
| ISAACS STEPHEN T | President and CEO | 04/03/2017 | 280,429 |
| ISAACS STEPHEN T | President and CEO | 03/13/2017 | 14,182 |
| ISAACS STEPHEN T | President and CEO | 03/13/2017 | 309,434 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 03/09/2017 | 3,600 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 03/09/2017 | 88,001 |
| Dubensky Thomas W. | Chief Scientific Officer | 03/09/2017 | 19,446 |
| Dubensky Thomas W. | Chief Scientific Officer | 03/09/2017 | 274,078 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 01/17/2017 | 3,600 |
| Brockstedt Dirk G. | EVP of Research and Dev. | 01/17/2017 | 94,858 |
| Templeman Blaine | Executive VP, General Counsel | 01/11/2017 | 45,231 |
| Dubensky Thomas W. | Chief Scientific Officer | 01/03/2017 | 13,000 |
| Dubensky Thomas W. | Chief Scientific Officer | 01/03/2017 | 278,990 |
| ISAACS STEPHEN T | President and CEO | 01/03/2017 | 14,182 |
| ISAACS STEPHEN T | President and CEO | 01/03/2017 | 303,289 |
| SCHAFER GREGORY W | Chief Operating Officer | 12/23/2016 | 28,700 |
| ISAACS STEPHEN T | President and CEO | 12/01/2016 | 14,182 |
| ISAACS STEPHEN T | President and CEO | 12/01/2016 | 295,169 |
| Dubensky Thomas W. | Chief Scientific Officer | 12/01/2016 | 25,893 |
| Dubensky Thomas W. | Chief Scientific Officer | 12/01/2016 | 273,500 |
| Haghighat Ross | Director | 11/14/2016 | 109,864 |
| ISAACS STEPHEN T | President and CEO | 11/14/2016 | 14,182 |
| ISAACS STEPHEN T | President and CEO | 11/14/2016 | 416,050 |
| Lew Jennifer | Sr. Vice President of Finance | 11/10/2016 | 8,946 |
| Lew Jennifer | Sr. Vice President of Finance | 11/10/2016 | 163,104 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/11/2016 | 43,709 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/10/2016 | 72,291 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/10/2016 | 734,698 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/11/2016 | 448,033 |
| Dubensky Thomas W. | Chief Scientific Officer | 11/10/2016 | 32,588 |
| Dubensky Thomas W. | Chief Scientific Officer | 11/10/2016 | 369,408 |
| ISAACS STEPHEN T | President and CEO | 10/03/2016 | 14,182 |
| ISAACS STEPHEN T | President and CEO | 10/03/2016 | 345,522 |
| Dubensky Thomas W. | Chief Scientific Officer | 10/03/2016 | 27,437 |
| Dubensky Thomas W. | Chief Scientific Officer | 10/03/2016 | 316,908 |
| Lew Jennifer | Sr. Vice President of Finance | 09/19/2016 | 4,473 |
| Lew Jennifer | Sr. Vice President of Finance | 09/19/2016 | 95,082 |
| Dubensky Thomas W. | Chief Scientific Officer | 09/01/2016 | 28,259 |
| Dubensky Thomas W. | Chief Scientific Officer | 09/01/2016 | 350,775 |
| Dubensky Thomas W. | Chief Scientific Officer | 08/11/2016 | 24,625 |
| Dubensky Thomas W. | Chief Scientific Officer | 08/11/2016 | 379,500 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/05/2016 | 25,963 |
| Dubensky Thomas W. | Chief Scientific Officer | 07/05/2016 | 290,250 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 05/16/2016 | 7,421 |
| SCHAFER GREGORY W | Chief Operating Officer | 05/16/2016 | 7,421 |
| Dubensky Thomas W. | Chief Scientific Officer | 05/16/2016 | 7,421 |
| Morningside Venture (VI) Investments Ltd | 10% Owner | 02/18/2016 | 76,097 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 01/11/2016 | 10,856 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 01/11/2016 | 479,015 |
| SCHAFER GREGORY W | Chief Operating Officer | 01/08/2016 | 20,000 |
| SCHAFER GREGORY W | Chief Operating Officer | 01/08/2016 | 471,600 |
| Dubensky Thomas W. | Chief Scientific Officer | 01/04/2016 | 70,158 |
| Dubensky Thomas W. | Chief Scientific Officer | 01/04/2016 | 395,531 |
| ISAACS STEPHEN T | President and CEO | 01/05/2016 | 6,500 |
| ISAACS STEPHEN T | President and CEO | 01/04/2016 | 6,500 |
| ISAACS STEPHEN T | President and CEO | 01/05/2016 | 328,196 |
| ISAACS STEPHEN T | President and CEO | 01/04/2016 | 329,603 |
| Lew Jennifer | Sr. Vice President of Finance | 01/06/2016 | 4,298 |
| Lew Jennifer | Sr. Vice President of Finance | 01/06/2016 | 134,765 |
| ISAACS STEPHEN T | President and CEO | 12/31/2015 | 4,500 |
| Lew Jennifer | Sr. Vice President of Finance | 12/29/2015 | 3,444 |
| SCHAFER GREGORY W | Chief Operating Officer | 12/24/2015 | 12,300 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 12/16/2015 | 17,400 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 12/10/2015 | 36,250 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 12/10/2015 | 745,423 |
| SCHAFER GREGORY W | Chief Operating Officer | 12/07/2015 | 36,250 |
| SCHAFER GREGORY W | Chief Operating Officer | 12/07/2015 | 743,571 |
| Lew Jennifer | Sr. Vice President of Finance | 12/03/2015 | 4,298 |
| Lew Jennifer | Sr. Vice President of Finance | 12/03/2015 | 156,486 |
| ISAACS STEPHEN T | President and CEO | 12/01/2015 | 13,000 |
| ISAACS STEPHEN T | President and CEO | 12/01/2015 | 727,664 |
| Dubensky Thomas W. | Chief Scientific Officer | 12/01/2015 | 64,373 |
| Dubensky Thomas W. | Chief Scientific Officer | 12/01/2015 | 878,104 |
| Greenman William Mariner | Director | 11/30/2015 | 91,950 |
| Lew Jennifer | Sr. Vice President of Finance | 11/18/2015 | 4,298 |
| Lew Jennifer | Sr. Vice President of Finance | 11/18/2015 | 191,426 |
| ISAACS STEPHEN T | President and CEO | 11/16/2015 | 13,000 |
| ISAACS STEPHEN T | President and CEO | 11/16/2015 | 688,490 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/17/2015 | 13,220 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/16/2015 | 2,679 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/17/2015 | 545,734 |
| Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/16/2015 | 204,294 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/16/2015 | 14,242 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/17/2015 | 22,008 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/17/2015 | 434,072 |
| SCHAFER GREGORY W | Chief Operating Officer | 11/16/2015 | 311,168 |
| Dubensky Thomas W. | Chief Scientific Officer | 11/17/2015 | 29,753 |
| Dubensky Thomas W. | Chief Scientific Officer | 11/16/2015 | 13,747 |
| Dubensky Thomas W. | Chief Scientific Officer | 11/17/2015 | 587,822 |
| Dubensky Thomas W. | Chief Scientific Officer | 11/16/2015 | 301,733 |
| ISAACS STEPHEN T | President and CEO | 07/24/2015 | 609 |
| Rogers John E. and Lois A. | 10% Owner | 04/20/2015 | 127,500 |
| Rogers John E. and Lois A. | 10% Owner | 04/20/2015 | 170,000 |
| Rogers John E. and Lois A. | 10% Owner | 04/20/2015 | 2,499,986 |
| Morningside Venture (VI) Investments Ltd | 10% Owner | 04/20/2015 | 7,499,992 |
| OBrien Stephanie Monaghan | Director | 04/20/2015 | 28,900 |
| OBrien Stephanie Monaghan | Director | 04/20/2015 | 28,900 |
| Greenman William Mariner | Director | 04/20/2015 | 51,000 |
| Lew Jennifer | Sr. Vice President of Finance | 04/20/2015 | 34,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR CHINOOK THERAPEUTICS INC
STOCK BUYBACKS FOR CHINOOK THERAPEUTICS INC
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
1.26%
1Q
12/31/2022
3.35%
2Q
09/30/2022
5.63%
3Q
06/30/2022
15.50%
4Q
03/31/2022
22.72%
5Q
12/31/2021
38.37%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CHINOOK THERAPEUTICS INC
LOADING...